Tyler Eugene Miller, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 12 | 2018 | 1376 | 0.820 |
Why?
|
| Glioblastoma | 12 | 2021 | 3481 | 0.750 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 817 | 0.570 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2017 | 166 | 0.550 |
Why?
|
| Antibodies, Viral | 7 | 2022 | 3176 | 0.410 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1372 | 0.410 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2014 | 1221 | 0.360 |
Why?
|
| Molecular Targeted Therapy | 3 | 2017 | 2727 | 0.350 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 3598 | 0.340 |
Why?
|
| Cerebellum | 2 | 2015 | 1490 | 0.320 |
Why?
|
| Brain Neoplasms | 10 | 2018 | 8860 | 0.310 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 323 | 0.300 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 850 | 0.300 |
Why?
|
| Tamoxifen | 1 | 2008 | 981 | 0.230 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2017 | 1341 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2017 | 987 | 0.200 |
Why?
|
| Seroepidemiologic Studies | 4 | 2023 | 402 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2016 | 5169 | 0.170 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2017 | 182 | 0.170 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2018 | 3 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 3871 | 0.170 |
Why?
|
| Mosaicism | 1 | 2021 | 441 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 3 | 2022 | 2013 | 0.150 |
Why?
|
| Mevalonic Acid | 1 | 2017 | 42 | 0.150 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 1978 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2016 | 66 | 0.140 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2016 | 121 | 0.140 |
Why?
|
| Miconazole | 1 | 2015 | 7 | 0.130 |
Why?
|
| Clobetasol | 1 | 2015 | 34 | 0.130 |
Why?
|
| Neurons | 1 | 2014 | 9335 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 3557 | 0.130 |
Why?
|
| Myelin Sheath | 2 | 2018 | 655 | 0.130 |
Why?
|
| MicroRNAs | 3 | 2017 | 3747 | 0.130 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.130 |
Why?
|
| Annexin A7 | 1 | 2014 | 3 | 0.130 |
Why?
|
| Ependymoma | 1 | 2017 | 334 | 0.120 |
Why?
|
| RNA Interference | 3 | 2018 | 2890 | 0.120 |
Why?
|
| Glycine Agents | 1 | 2013 | 17 | 0.120 |
Why?
|
| Thrombospondins | 1 | 2014 | 197 | 0.120 |
Why?
|
| Receptors, Transferrin | 1 | 2015 | 296 | 0.120 |
Why?
|
| Amacrine Cells | 1 | 2013 | 53 | 0.120 |
Why?
|
| Purines | 1 | 2017 | 594 | 0.120 |
Why?
|
| Adenine | 1 | 2018 | 936 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 8426 | 0.110 |
Why?
|
| Ferritins | 1 | 2015 | 590 | 0.110 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3132 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 635 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3239 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1176 | 0.100 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 7723 | 0.100 |
Why?
|
| Oncogenes | 1 | 2017 | 1265 | 0.100 |
Why?
|
| Immunoglobulin M | 3 | 2020 | 1538 | 0.100 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 2183 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 14726 | 0.100 |
Why?
|
| Mice | 12 | 2018 | 81178 | 0.090 |
Why?
|
| Cell Survival | 2 | 2018 | 5881 | 0.090 |
Why?
|
| Epigenesis, Genetic | 4 | 2017 | 3646 | 0.090 |
Why?
|
| Protein Methyltransferases | 1 | 2010 | 55 | 0.090 |
Why?
|
| Cell Proliferation | 5 | 2017 | 10480 | 0.090 |
Why?
|
| Epithelium | 1 | 2014 | 1680 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 2942 | 0.090 |
Why?
|
| Mitosis | 1 | 2014 | 1208 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 1708 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 16687 | 0.080 |
Why?
|
| Cell Lineage | 2 | 2014 | 2504 | 0.080 |
Why?
|
| RNA, Ribosomal | 1 | 2010 | 247 | 0.080 |
Why?
|
| Mitochondria | 1 | 2022 | 3520 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2014 | 1118 | 0.080 |
Why?
|
| Cross Reactions | 2 | 2020 | 841 | 0.080 |
Why?
|
| Histones | 3 | 2018 | 2600 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 795 | 0.080 |
Why?
|
| Signal Transduction | 8 | 2018 | 23404 | 0.080 |
Why?
|
| Animals | 15 | 2018 | 168788 | 0.080 |
Why?
|
| Humans | 29 | 2023 | 744220 | 0.070 |
Why?
|
| Iron | 1 | 2015 | 1774 | 0.070 |
Why?
|
| Immunoglobulin A | 2 | 2020 | 992 | 0.070 |
Why?
|
| Hospitals | 1 | 2020 | 3952 | 0.070 |
Why?
|
| DNA Methylation | 2 | 2018 | 4289 | 0.070 |
Why?
|
| Chromatin | 1 | 2017 | 2934 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 9735 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3584 | 0.060 |
Why?
|
| High-Throughput Screening Assays | 2 | 2021 | 945 | 0.060 |
Why?
|
| Immunoglobulin G | 3 | 2020 | 4559 | 0.060 |
Why?
|
| Disease Progression | 2 | 2018 | 13280 | 0.060 |
Why?
|
| Oligodendroglia | 2 | 2018 | 519 | 0.060 |
Why?
|
| Retina | 1 | 2013 | 2616 | 0.050 |
Why?
|
| Receptors, Notch | 2 | 2016 | 739 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 20817 | 0.050 |
Why?
|
| Methylation | 2 | 2016 | 1108 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 3079 | 0.050 |
Why?
|
| Female | 9 | 2020 | 380197 | 0.050 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2008 | 1509 | 0.040 |
Why?
|
| Remote Sensing Technology | 1 | 2021 | 90 | 0.040 |
Why?
|
| Mutation | 2 | 2022 | 29784 | 0.040 |
Why?
|
| Blood Specimen Collection | 1 | 2021 | 246 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 634 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2017 | 2716 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2020 | 1095 | 0.040 |
Why?
|
| Male | 7 | 2020 | 350027 | 0.040 |
Why?
|
| Coronavirus | 1 | 2020 | 158 | 0.040 |
Why?
|
| Fingers | 1 | 2021 | 514 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2017 | 12207 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2017 | 6313 | 0.040 |
Why?
|
| Massachusetts | 2 | 2020 | 8663 | 0.040 |
Why?
|
| Ribose-Phosphate Pyrophosphokinase | 1 | 2017 | 9 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9438 | 0.040 |
Why?
|
| Immunoassay | 1 | 2020 | 752 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2018 | 19227 | 0.040 |
Why?
|
| Pandemics | 3 | 2021 | 8387 | 0.030 |
Why?
|
| Middle Aged | 5 | 2020 | 213367 | 0.030 |
Why?
|
| Heterochromatin | 1 | 2018 | 296 | 0.030 |
Why?
|
| Epitopes | 1 | 2022 | 2571 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 675 | 0.030 |
Why?
|
| Base Sequence | 2 | 2017 | 12801 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 12075 | 0.030 |
Why?
|
| Lysophosphatidylcholines | 1 | 2015 | 81 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 77426 | 0.030 |
Why?
|
| Adenosine Monophosphate | 1 | 2017 | 275 | 0.030 |
Why?
|
| Germ Layers | 1 | 2015 | 73 | 0.030 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2014 | 26 | 0.030 |
Why?
|
| Transferrin | 1 | 2015 | 295 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2014 | 70 | 0.030 |
Why?
|
| Protein Binding | 2 | 2016 | 9392 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2016 | 321 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 290 | 0.030 |
Why?
|
| Adult | 7 | 2022 | 214035 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 1085 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1660 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 302 | 0.030 |
Why?
|
| Epigenomics | 1 | 2018 | 903 | 0.030 |
Why?
|
| Time Factors | 2 | 2020 | 40063 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 826 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 5529 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 1877 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2015 | 363 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 1008 | 0.030 |
Why?
|
| Models, Biological | 1 | 2008 | 9582 | 0.030 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2017 | 871 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 2085 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 769 | 0.020 |
Why?
|
| Astrocytes | 1 | 2018 | 1270 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 484 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2020 | 6461 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5076 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2015 | 1284 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4752 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8321 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2016 | 1639 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2015 | 835 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1655 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2023 | 6196 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3505 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2018 | 11478 | 0.020 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2010 | 131 | 0.020 |
Why?
|
| Cell Division | 1 | 2016 | 4567 | 0.020 |
Why?
|
| Metabolomics | 1 | 2017 | 1483 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2016 | 2967 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 1613 | 0.020 |
Why?
|
| Exons | 1 | 2014 | 2439 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 2948 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 1294 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 18027 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6535 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1525 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10250 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4217 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 1736 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4201 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12244 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10387 | 0.020 |
Why?
|
| Regeneration | 1 | 2015 | 1485 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 7326 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 2636 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2010 | 3129 | 0.010 |
Why?
|
| Proteomics | 1 | 2016 | 3637 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15538 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 19907 | 0.010 |
Why?
|
| Glioma | 1 | 2017 | 3401 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 25043 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5853 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5892 | 0.010 |
Why?
|
| Genomics | 1 | 2017 | 5722 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 9728 | 0.010 |
Why?
|
| Child | 2 | 2018 | 77679 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2014 | 13036 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 40559 | 0.010 |
Why?
|
| Phenotype | 1 | 2015 | 16365 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 163253 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 4665 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 29050 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 63119 | 0.010 |
Why?
|
| Brain | 1 | 2016 | 26413 | 0.010 |
Why?
|